NovelSOX17frameshift mutations in endometrial cancer are functionally distinct from recurrent missense mutations
Open Access
- 12 August 2017
- journal article
- research article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (40) , 68758-68768
Abstract
Novel SOX17 frameshift mutations in endometrial cancer are functionally distinct from recurrent missense mutations Novel SOX17 frameshift mutations in endometrial cancer are functionally distinct from recurrent missense mutationsKeywords
This publication has 50 references indexed in Scilit:
- Promoter methylation of Wnt-antagonists in polypoid and nonpolypoid colorectal adenomasBMC Cancer, 2013
- Signatures of mutational processes in human cancerNature, 2013
- Integrated genomic characterization of endometrial carcinomaNature, 2013
- A framework for variation discovery and genotyping using next-generation DNA sequencing dataNature Genetics, 2011
- Improving the Assessment of the Outcome of Nonsynonymous SNVs with a Consensus Deleteriousness Score, CondelThe American Journal of Human Genetics, 2011
- Sox17 modulates Wnt3A/β-catenin-mediated transcriptional activation of the Lef-1 promoterAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2010
- The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing dataGenome Research, 2010
- Epigenetic Inactivation of the Canonical Wnt Antagonist SRY-Box Containing Gene 17 in Colorectal CancerCancer Research, 2008
- Sox17 and Sox4 Differentially Regulate β-Catenin/T-Cell Factor Activity and Proliferation of Colon Carcinoma CellsMolecular and Cellular Biology, 2007
- Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined FactorsCell, 2006